Alamar Biosciences, Inc. (ALMR) Reports Q2 Loss of $0.22

Alamar Biosciences, Inc. (NASDAQ: ALMR) reported Q2 EPS of ($0.22). Revenue for the quarter came in at $29.4 million.

For earnings history and earnings-related data on Alamar Biosciences, Inc. (ALMR) click here.

You May Also Be Interested In

• Carnival Corp. (CCL) call put ratio 4.6 calls to 1 put with a focus on with a focus on September 4 weekly 24.50 calls as share price up 2.7%
• Meeting Nutrition and Sustainability Needs With Hybrid Protein Products
• OPEC+ meeting Sunday will not make any output policy decision - Reuters